Member Info for miavoce

Sounds like we agree TF. There is no reason why M.Diggle should know about day to day events, nor is there any reason why he shouldn't.

As long as they aren't aware of impending events that will move the SP then M.Diggle / Vulpes are free to buy and sell shares whenever they want. Being a non-exec does not necessarily mean that M.Diggle has day to day operational knowledge of when events happen, and if he does not then the fact that Vulpes bought shares last week does not mean that news is not imminent. It may well be that M.Diggle has specifically asked not to be kept in the loop with day to day events in order to avoid a situation where Vulpes cannot trade die to his inside knowledge (there is no reason why a non-exec should be kept aware of day to day progress and events as non-execs aren't involved in the day to day running of the co.).

If SCLP can finish blue as well this will be one of the most remarkable days I have seen as far as SP turnarounds go...

Big update posted today on the SCIB1 trial details:-

https://clinicaltrials.gov/ct2/show/NCT04079166?term=scancell&draw=2&rank=1

Scroll down to the bottom and click on 'History of Changes' to see a side by side comparison with the previous version. You'll see that the duration of the trial has reduced significantly.

Maybe this is a sign that things are on the move....

Big update posted today on the SCIB1 trial details:-

hTTps://clinicaltrials.gov/ct2/show/NCT04079166?term=scancell&draw=2&rank=1

Scroll down to the bottom and click on 'History of Changes' to see a side by side comparison with the previous version. You'll see that the duration of the trial has reduced significantly.

Maybe this is a sign that things are on the move....

mmm....so Redmile put £50m into a lifestyle share did they....don't think so.

Generally good sign to have EK supporting a share

Given the strength so far today I can see it ending the day in the 120's

Th kind of Pharma that would buy AGL would be one that has a significant focus on diagnostics such as Abbott or Thermo Fisher. Given then the potential profit that Parsortix could generate for them they will be keen to acquire AGL IMO.

Turning Angle into a global giant will be AN's life's work from now on - no way IMO will he be taking his eye off that ball (unless a major pharma swoops in with an offer that can't be refused).

Should see a continuation on Monday given the strength into the close

Thanks LL

Where did the 'end H1' target come from btw ? I can't remember that being mentioned in any of the press ?

Any day without news is a good day and should be welcomed because:-

a) no bad news
b) a day closer to the news

Good price recovery today - maybe the next leg up is indeed imminent.

Hopefully this is the start of positive news flow over the next few months with the following to come:-

- contract updates (one or more in April and hopefully fairly regularly thereafter)
- confirmation of response to FDA (early May)
- Ovarian update
- Result of Basel trial on cluster busting drugs (June)
- FDA outcome (June/July)
- More research papers / journal publications
- Results
- Nasdaq update
- etc

Giving it it's own thread.

32 minutes ago CEPI retweeted their article which mentions Scancell

https://twitter.com/CEPIvaccines/status/1376488095948931073

32 minutes ago CEPI retweeted their article which mentions Scancell

https://twitter.com/CEPIvaccines/status/1376488095948931073

I agree iceman888, seemed to start on Friday and has carried across to today despite no press over the weekend. News incoming ?

https://twitter.com/Coronavirusgoo1/status/1371062416390361088

From the tweet:
The UK has given over 10 million doses of both the Oxford and Pfizer vaccine.
Number of blood clot related events:
Oxford = 13
Pfizer = 15
These numbers are no higher than what is seen in the general population (no increased risk).